Profile drugs with FDA regulatory exclusivity

Aug. 23, 2010 - PRLog -- Adding to its robust set of pharmaceutical drug information, DrugPatentWatch.com has added to ability to search by regulatory exclusivity.

New search filters include:

- NEW CHEMICAL ENTITY
- NEW COMBINATION
- NEW DOSAGE FORM
- NEW DOSING SCHEDULE
- NEW ESTER OR SALT
- NEW INDICATION
- NEW PRODUCT
- NEW PATIENT POPULATION
- NEW ROUTE
- NEW STRENGTH
- ORPHAN DRUG EXCLUSIVITY
- PATENT CHALLENGE
- PEDIATRIC EXCLUSIVITY
- OTC SWITCH
- EXCLUSIVITY WAIVED BY SPONSOR

These new search filters add to DrugPatentWatch's robust suite, which supports the critical business  patent agents and attorneys, generic and branded pharmaceutical companies, wholesalers, healthcare payers, and investors.

A preview of the DrugPatentWatch.com database is available at http://www.drugpatentwatch.com/ultimate/preview/ and a site tour is available at
http://www.drugpatentwatch.com/tour/

# # #

DrugPatentWatch provides comprehensive information on drug patents and their expirations.This value-added information supports patent agents and attorneys, pharmaceutical companies, wholesalers, healthcare payers, and investors.